RX-af01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RX-af01, covering 2024-01-23 to 2024-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of RX-af01 Combined With PD-1 Antibody [Phase 1, Phase 2]